Iqvia, Medpace send CRO peers higher after Q2 beats

12 hours ago 1
Quarterly results

CharlieAJA/iStock via Getty Images

Shares of contract research organizations climbed in the premarket on Tuesday after two industry leaders, IQVIA Holdings (NYSE:IQV) and Medpace Holdings (NASDAQ:MEDP), posted better-than-expected results for Q2 2025.

While Iqvia (NYSE:IQV) and Medpace (NASDAQ:MEDP) added ~8% and ~45%

Recommended For You

More Trending News

Read Entire Article